DOI: 10.1093/jncimonographs/lgq040 © The Author 2010. Published by Oxford University Press. All rights reserved.
For Permissions, please e-mail: journals.permissions@oxfordjournals.org.
Choosing Treatment for Patients With Ductal Carcinoma In Situ: Fine Tuning the University of Southern California/Van Nuys Prognostic Index
Melvin J. Silverstein, Michael D. Lagios
Correspondence to: Melvin J. Silverstein, MD, FACS, Department of Surgery, Hoag Breast Center, One Hospital Road, Newport Beach, CA 92658 (e-mail: melsilver9@gmail.com).
The University of Southern California/Van Nuys Prognostic Index is an algorithm that quantifies five measurable prognostic factors known to be important in predicting local recurrence in conservatively treated patients with ductal carcinoma in situ (tumor size, margin width, nuclear grade, age, and comedonecrosis). With three times as many patients since originally developed, sufficient numbers now exist for analysis by individual scores rather than groups of scores. To achieve a local recurrence rate of less than 20% at 12 years, these data support excision alone for all patients scoring 4, 5, or 6 and patients who score 7 but have margin widths ≥3 mm. Excision plus RT achieves the less than 20% local recurrence require-ment at 12 years for patients who score 7 and have margins <3 mm, patients who score 8 and have margins ≥ 3 mm, and for patients who score 9 and have margins ≥5 mm. Mastectomy is required for patients who score 8 and have margins <3 mm, who score 9 and have margins <5 mm, and for all patients who score 10, 11, or 12 to keep the local recurrence rate less than 20% at 12 years. These recommendations in this article represent substantial changes from those previously published.
J Natl Cancer Inst Monogr 2010;41:193–196
In 2008, the National Comprehensive Cancer Network included prognosis to 3 for lesions with the worst prognosis, was given for excision alone as an acceptable treatment alternative for patients each of the four prognostic predictors. Table 1 details the scoring with ductal carcinoma in situ (DCIS), but they did not define the system. Scores range from a low of 4 (least likely to recur) to a high subset of patients in which excision without radiation therapy was of 12 (most likely to recur).
appropriate (1). Researchers have attempted to accomplish this for years but only with marginal success.
Current recommendations are as follows:Multivariate analysis has shown that six factors are independent Excision alone for those who score 4, 5, or 6.
predictors of local recurrence in patients with DCIS treated with Excision plus radiation therapy for those who score 7, 8, or 9.breast conservation: treatment (radiation therapy yields a lower Mastectomy for those who scored 10, 11, or 12.
local recurrence rate than excision alone), age (older age is better), This article will use the USC/VNPI to analyze local recurrence size (smaller size is better), nuclear grade (lower grade is better), rates and to update and refine treatment recommendations in a margin width (wider margins are better), and comedonecrosis (no large series of patients with pure DCIS in whom all histopatho-necrosis is better) (2–4).
logical factors were collected within a prospective database. When In 1995, the Van Nuys Classification predicted local recur-originally published in 1996, the Index was based on 333 patients rence using a combination of nuclear grade and necrosis (5). In (6). With three times as many patients accrued since originally 1996, the Van Nuys Prognostic Index (VNPI) added size and described, sufficient numbers of patients now exist for analysis by margin width to the numerical algorithm (6), and in 2002, the individual score rather than groups of scores.
University of Southern California/VNPI (USC/VNPI) added age at diagnosis to the algorithm (4,7). These studies collected all pathological features in a prospective fashion but treatment (exci-Methods
sion alone vsversus excision plus radiation therapy) was not Through April 2009, 1437 patients with pure DCIS were treated. randomized.
No patients with invasive cancer, no matter how small the invasive The USC/VNPI was devised by combining four statistically focus, were included. A total of 488 patients were treated with mas-significant independent prognostic factors for local tumor recur-tectomy and, therefore, did not have the ipsilateral breast at risk for rence (tumor size, margin width, pathological classification [deter-local recurrence. They were excluded in this analysis.
mined by nuclear grade and the presence or absence of comedo-type The subjects of this article are 949 patients treated with breast necrosis] and age). A score, ranging from 1 for lesions with the best
conservation, 345 with excision and radiation therapy, and 604
Journal of the National Cancer Institute Monographs, No. 41, 2010
193
Downloaded from doc.guandang.net at Taipei Medical University Library on July 17, 2013
乳腺癌_医药卫生_专业资料。ppt,将的很详细乳腺癌 (breast cancer ) 前言 ? 乳腺癌是女性常见的恶性肿瘤 ? 全世界每年有120万妇女发生乳腺癌,50 万死于乳腺...
2014乳腺癌现状_临床医学_医药卫生_专业资料。中国乳腺癌现状(综述)本篇文章综述了目前中国乳腺癌的现状,于 2014 年 6 月 15 日由 Fan Lei 等发表 在 ...
乳腺癌术后的饮食指导 1、菜花类蔬菜:卷心菜、大白菜、黄花菜等 以上蔬菜含有一种氨化合物,名叫吲哚-3-甲醛,具有转变雌激素、预防乳腺癌的作用, 因此建议乳腺癌...
乳腺癌的早期症状_医药卫生_专业资料。近年来乳腺癌已经成为了威胁女性健康的第一杀手,女性对于乳腺癌的重视程度也变得越来越高。乳腺癌的症状,早期乳房内可触及...
乳腺癌手术后的饮食全网发布:2012-07-20 18:03 发表者:肖晖 (访问人次:16800) 1.任何乳腺疾病当然乳腺癌也不例外,无论术前术后均可多食海带、海藻、紫菜、...
乳腺癌术后饮食 对于女性朋友来说,患上乳腺癌或许是最难以承受的。疾病缠身,还得经历切除 乳房的痛苦。可谓是心理生理上的双重打击。这个时候,女人是脆弱的,极其需...
了解乳腺癌的早期症状乳癌的早期发现 众所周知,癌瘤并非“不治之症” ,关键是能否 做到早期发现和早期治疗。多年来,临床实践已经证实,对大多数癌 瘤来说,若想提高...
乳腺癌的早期症状近年来,乳腺癌已成为危害我们广大女性朋友的重大疾病之一,我们都知道 乳腺癌给女性带来了极大的困扰和痛苦。 下面就让我们和专家一起来具体的了解 ...
乳腺癌的早期症状_基础医学_医药卫生_专业资料。小编主要阐述乳腺癌的早期症状,供读者参考。乳腺癌的早期症状乳房是女性魅力的重要标志, 那么,乳腺癌的早期症状是...
乳腺癌术后饮食要注意哪些很多患都在手术治疗后会出现失血、术后食欲减退、消化吸收功能下降、大便 不畅等现象,导致营养不良,这对术后身体恢复带来了严重影响,所以...
热门文档